Pharmacotherapy of Schizophrenia

This presentation is by the outstanding researcher in this field, John M. Kane, M.D., Chairman of Psychiatry at L.I. Jewish Medical Center, and Professor of Psychiatry at Albert Einstein College of Medicine. As in all the videotapes, easily read slides illustrate the major issues and treatment considerations, and the latest findings on the effectiveness as well as on the side effects of the many and varied psychopharmacological agents are carefully illustrated and discussed.

American Psychiatric Publishing

Deals w/mgmt of trmt resistant patients/optimum strategies for relapse prevention/epidemiology of Tardive Dyskinesia.

This presentation is by the outstanding researcher in this field, John M. Kane, M.D., Chairman of Psychiatry at L.I. Jewish Medical Center, and Professor of Psychiatry at Albert Einstein College of Medicine. As in all the videotapes, easily read slides illustrate the major issues and treatment considerations, and the latest findings on the effectiveness as well as on the side effects of the many and varied psychopharmacological agents are carefully illustrated and discussed.

John M. Kane, M.D., is Chair of the Department of Psychiatry at Hillside Hospital, a division of Long Island Jewish Medical Center and Professor of Psychiatry at the Albert Einstein College of Medicine. He currently directs the NIMH-funded Clinical Research Center for the Study of Schizophrenia at the Hillside Hospital division of Long Island Jewish Medical Center, Glen Oaks, New York.